A Phase I/II Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors
Phase of Trial: Phase I/II
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Gemcitabine; Romidepsin
- Indications Pancreatic cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 10 Aug 2012 Actual end date (1 Jul 2008) added as reported by ClinicalTrials.gov.
- 15 Mar 2011 Company added in association field as reported by ClinicalTrials.gov.
- 15 Sep 2006 New trial record.